The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Rasmussen TR, Jakobsen E. Dansk Lunge Cancer Register. National årsrapport 2017. DLCG. 2018;13:50–75.
   Google Scholar
• Verma V, Simone CB, 2nd, Werner-Wasik M. Acute and late toxicities of concurrent chemoradiotherapy for locally-advanced non-small cell lung cancer. Cancers. 2017;9:120.
   Web of Science ®Google Scholar
• Auperin A, Le Pechoux C, Rolland E, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. JCO. 2010;28:2181–2190.
   PubMed Web of Science ®Google Scholar
• McWilliam A, Vasquez Osorio E, Faivre-Finn C, et al. Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy. Radiother Oncol. 2019;137:71–76.
   PubMed Web of Science ®Google Scholar
• Jia B, Zheng Q, Qi X, et al. Survival comparison of right and left side non-small cell lung cancer in stage I-IIIA patients: a surveillance epidemiology and end results (SEER) analysis. Thorac Cancer. 2019;10:459–471.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Fakhreddine M, et al. Trends in cardiac mortality in patients with locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2018;1;100:470–477.
   PubMed Web of Science ®Google Scholar
• Hahn E, Jiang H, Ng A, et al. Late cardiac toxicity after mediastinal radiation therapy for hodgkin lymphoma: contributions of coronary artery and whole heart dose-volume variables to risk prediction. Int J Radiat Oncol Biol Phys. 2017;98:1116–1123.
   PubMed Web of Science ®Google Scholar
• van Nimwegen FA, Schaapveld M, Cutter DJ, et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. JCO. 2016;34:235–243.
   PubMed Web of Science ®Google Scholar
• Montes HZ. TNM classification of malignant tumors, 7th edition. Int J Radiat Oncol Biol Phys. 2010;78:1278.
   Google Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.
   PubMed Web of Science ®Google Scholar
• Hansen O, Knap MM, Khalil A, et al. A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC. Radiother Oncol. 2017;123:276–281.
   PubMed Web of Science ®Google Scholar
• Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3:46–52.
   PubMed Web of Science ®Google Scholar
• Sardar P, Kundu A, Chatterjee S, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer: a systematic review and meta-analysis. Clin Cardiol. 2017;40:73–81.
   PubMed Web of Science ®Google Scholar
• Haque R, Yood MU, Geiger AM, et al. Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomarkers Prev. 2011;20:2120–2126.
   PubMed Web of Science ®Google Scholar
• Li WH, Zhang ZG, Huang ZR, et al. No association between tumor laterality and cardiac-related mortality in breast cancer patients after radiotherapy: a population-based study. CMAR. 2018;10:3649–3656.
   Web of Science ®Google Scholar
• Koshy M, Goloubeva O, Suntharalingam M. Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;79:1388.
   PubMed Web of Science ®Google Scholar
• Puri V, Garg N, Engelhardt EE, et al. Tumor location is not an independent prognostic factor in early stage non-small cell lung cancer. Ann Thorac Surg. 2010;89:1053–1059.
   PubMed Web of Science ®Google Scholar
• Lally BE, Geiger AM, Urbanic JJ, et al. Trends in the outcomes for patients with limited stage small cell lung cancer: an analysis of the surveillance, epidemiology, and end results database. Lung Cancer. 2009;64:226–231.
   PubMed Web of Science ®Google Scholar
• Alghamdi HI, Alshehri AF, Farhat GN. An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients. J Epidemiol Global Health. 2018;7:S1–s6.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–998.
   PubMed Web of Science ®Google Scholar
• Schytte T, Hansen O, Stolberg-Rohr T, et al. Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer. Acta Oncol (Stockholm, Sweden). 2010;49:1058–1060.
   PubMed Web of Science ®Google Scholar